Exp Clin Endocrinol Diabetes 2024; 132(03): 125-135
DOI: 10.1055/a-2166-6695
Therapie des Typ-1-Diabetes

Therapy for Type 1 Diabetes

Abridged Version of the S3 Guideline (AWMF Register Number: 057-013; 4th Edition, 2018)
Thomas Haak
1   Diabetes Centre Bad Mergentheim, Bad Mergentheim, Germany
,
Stefan Gölz
2   Diabetological Practice, Esslingen, Germany
,
Andreas Fritsche
3   Department of Internal Medicine IV, University Hospital Tübingen, Tübingen, Germany
,
Martin Füchtenbusch
4   Diabetes Centre am Marienplatz Munich, Munich, Germany
,
Thorsten Siegmund
5   Isar Hospital, Munich, Germany
,
Elisabeth Schnellbächer
6   Birkenfeld, Germany
,
Harald H. Klein
7   Department of Internal Medicine I - General Internal Medicine, Endocrinology and Diabetology, Gastroenterology and Hepatology, Bergmannsheil University Hospitals, Bochum, Germany
,
Til Uebel
8   prima-diab Practice Drs. Uebel/Nittka/Mayer/Merkle, Ittlingen, Germany
,
Diana Droßel
9   Eschweiler, Germany
› Author Affiliations
PreviewZoom

Notice of update

The DDG clinical practice guidelines are updated regularly during the second half of the calendar year. Please note that due to the overlap of the deadlines for the printing version of this clinical practice guideline and the publication of the 5th edition of the S3 guideline on the treatment of type 1 diabetes in September 2023, the present clinical practice guideline still refers to the version from 2018. The current long version of the S3 guideline (09/2023) can be found at: https://register.awmf.org/de/leitlinien/detail/057–013 and on the DDG homepage.



Publication History

Article published online:
16 February 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany